Key result
Nonsurgical septal reduction therapy (alcohol septal ablation) improves left ventricular outflow tract obstruction and symptoms in hypertrophic obstructive cardiomyopathy at 1 year follow-up.
Why the study?
Does nonsurgical septal reduction therapy (alcohol septal ablation) improve symptoms and left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy?
Population
Patients with hypertrophic obstructive cardiomyopathy
Design
Review
Follow-up
1 year
Authors
Loading...
May support alcohol septal ablation in select HOCM; leaves open need for randomized trials versus myectomy.
Does nonsurgical septal reduction therapy (alcohol septal ablation) improve symptoms and left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy?
Nonsurgical septal reduction therapy (alcohol septal ablation) is an effective percutaneous intervention for improving gradients and symptoms in hypertrophic obstructive cardiomyopathy, with complete heart block as the most common complication.
Nielsen et al. (2002) conducted a review in Hypertrophic obstructive cardiomyopathy. Nonsurgical septal reduction therapy (alcohol septal ablation) was evaluated. Nonsurgical septal reduction therapy (alcohol septal ablation) improves left ventricular outflow tract obstruction and symptoms in hypertrophic obstructive cardiomyopathy at 1 year follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: